This drug may reduce obesity-linked breast cancer
A new study suggests that the anti-obesity drug tirzepatide may help reduce the growth of breast cancer linked to obesity.
The research was presented at...
Surprising link between anti-nausea drug and breast cancer survival
A common anti-nausea medication used during chemotherapy may help women with early-stage breast cancer live longer, especially those with the aggressive triple-negative form.
That’s the...
How diabetes may worsen aggressive breast cancer
More than 120 million people in the U.S. have diabetes or pre-diabetes. At the same time, triple-negative breast cancer (TNBC) is the most aggressive...
New obesity drug may slow breast cancer growth
A new study has found that a drug used for treating obesity and type 2 diabetes may also help slow the growth of breast...
Common dietary fat boosts growth of aggressive breast cancer
A new preclinical study from Weill Cornell Medicine reveals that linoleic acid, a type of omega-6 fatty acid commonly found in seed oils and animal...
Breast cancer survivors may have lower risk of Alzheimer’s disease
A new study led by Samsung Medical Center has found that women who survive breast cancer may face a slightly lower risk of developing...
Low-dose vitamin D may boost chemotherapy outcomes in breast cancer
New research from São Paulo State University in Brazil suggests that a simple and affordable supplement—vitamin D—could help improve the effectiveness of chemotherapy in...
Scientists improve breast cancer treatment while reducing healthy tissue damage
Breast cancer is the most common type of cancer among women across the world. Scientists are working hard to find new and better ways...
Many women choose to extend breast cancer hormone therapy
Breast cancer is one of the most common cancers among women. Many types of breast cancer grow in response to hormones like estrogen or...
Menopause drug may also help prevent invasive breast cancer, early study finds
A drug already approved to treat menopause symptoms may also lower the risk of invasive breast cancer, according to new research from a phase...